News and Events
12/9/2008
Affymetrix Technology Powers Cincinnati Children's Hospital's Innovative Test for Jaundice
12/8/2008
Affymetrix Completes Acquisition of Panomics
Plant and Animal Genome XVII Conference
1/10/2009-1/14/2009
Achieving ROI in Personalized Medicine: Barriers, Incentives, and Pathways to Commercialization
1/27/2009-1/28/2009
Scientific Publications
News Articles
| Summary | Date |
|---|---|
| Gene Associated With Age-related Hearing Loss Identified The TGen team discovered a common variant in the GRM7 gene, which the research team believes may be associated with susceptibility to glutamate excitotoxicity and hearing loss. |
12/03/2008 |
| Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing Up to 10,000 Scripps employees are being offered personal genetic testing by Navigenics on Affymetrix' SNP Array 6.0. Volunteers will store results in their own Microsoft HealthVault™. |
10/09/2008 |
| Wellcome Trust Sanger Institute Uses Affymetrix Technology to Reveal Changes in 800 Cancer Cell Lines The Cancer Genome Project has recently completed the genome-wide analysis of copy number changes in a Core Set of cancer cell lines. Cancer cell lines are invaluable reagents in investigating the molecular biology of the disease as well as important tools in developing new therapeutic approaches. |
09/17/2008 |
| Research to Boost Cellulosic Ethanol Programs Oregon State University scientists work with Affymetrix to accelerate genomic research in cellulosic biofuel feedstock crops. |
08/01/2008 |
| EURASNET Consortium Evaluates the Performance of Different Microarrays for Studying Alternative Splicing European study finds that GeneChip® Human Exon Arrays outperform for alternative splicing research. |
07/12/2008 |
| Affymetrix technology featured in PBS' Nova: Science Now Neil deGrasse Tyson reports on how Navigenics is using Affymetrix technology to help people understand the health conditions for which they are at risk. |
07/02/2008 |
| Genetic Differences Between Ethnicities May Determine Breast Cancer Prognosis A team of researchers uses GeneChip®-based technology to discover hundreds of genetic differences between breast cancer patients of different ethnicities. |
07/02/2008 |
| Leading Cancer Researchers Cite Affymetrix Exon Array For Its 'Unprecedented Resolution' Scientists in Israel and France report clear advantages with Affymetrix technology over competing products. |
06/11/2008 |
| Student Uses Affymetrix Technology To Help Australian Grape Growers Seventeen-year-old Bindhu Holavanahalli wins third place at the Sanofi-Aventis International BioGENEius Challenge using the Affymetrix GeneChip® Grape Genome Array. |
05/07/2008 |
| Affymetrix Named One of the World's Top 50 Innovative Companies Life Sciences Pioneer Ranked 13th. |
03/06/2008 |
| New Genetic Discovery Helps Improve Warfarin Drug Dosing Dilemma Marshfield Clinic research team uses the Affymetrix DMET solution to discover a genetic variant that explains approximately eight percent of a patient's variable response to warfarin. |
01/31/2008 |
| Affymetrix Completes Acquisition of USB Corporation USB's extensive reagent platform will complement Affymetrix' current GeneChip® platform and accelerate the development of next-generation products. (Learn more about USB Corporation). |
01/31/2008 |
| Affymetrix Launches GeneChip® Xenopus laevis Genome 2.0 Array New array designed to monitor the gene expression of X. laevis, one of the most important model organisms. |
01/28/2007 |